We provide you with 20 years of free, institutional-grade data for VSTM stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VSTM. Explore the full financial landscape of VSTM stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Calkins Daniel | Sale | -57 | $7.93 | $452 | 2023-12-21 |
| Gagnon Robert E. | Sale | -414 | $7.64 | $3,163 | 2023-12-20 |
| Paterson Dan | Sale | -427 | $7.64 | $3,262 | 2023-12-20 |
| Stuglik Brian M | Sale | -761 | $7.64 | $5,814 | 2023-12-20 |
| Calkins Daniel | Sale | -5 | $7.3 | $37 | 2023-10-10 |
| Calkins Daniel | Sale | -257 | $9.31 | $2,393 | 2023-09-25 |
| Paterson Dan | Sale | -423 | $9.91 | $4,192 | 2023-09-20 |
| Gagnon Robert E. | Sale | -408 | $9.91 | $4,043 | 2023-09-20 |
| Stuglik Brian M | Sale | -752 | $9.91 | $7,452 | 2023-09-20 |
| Paterson Dan | Grant, award...etc | 50,000 | 2023-08-04 | ||
| Calkins Daniel | Sale | -5 | $8.02 | $40 | 2023-07-10 |
| Calkins Daniel | Sale | -26 | $8.17 | $212 | 2023-06-28 |
| Paterson Dan | Sale | -427 | $9.92 | $4,236 | 2023-06-21 |
| Gagnon Robert E. | Sale | -413 | $9.92 | $4,097 | 2023-06-21 |
| Stuglik Brian M | Sale | -762 | $9.92 | $7,559 | 2023-06-21 |
| Calkins Daniel | Sale | -75 | $0.37 | $28 | 2023-04-06 |
| Calkins Daniel | Sale | -378 | $0.42 | $159 | 2023-03-28 |
| Paterson Dan | Sale | -5,477 | $0.4 | $2,191 | 2023-03-20 |
| Gagnon Robert E. | Sale | -5,318 | $0.4 | $2,127 | 2023-03-20 |
| Stuglik Brian M | Sale | -9,784 | $0.4 | $3,914 | 2023-03-20 |
| Calkins Daniel | Sale | -74 | $0.43 | $32 | 2023-01-09 |
| Calkins Daniel | Sale | -1,246 | $0.33 | $411 | 2022-12-29 |
| Paterson Dan | Sale | -18,630 | $0.4 | $7,452 | 2022-12-20 |
| Stuglik Brian M | Sale | -28,718 | $0.4 | $11,487 | 2022-12-20 |
| Gagnon Robert E. | Sale | -13,837 | $0.4 | $5,535 | 2022-12-20 |
| Gagnon Robert E. | Initial | 2022-12-15 | |||
| Calkins Daniel | Initial | 2022-11-08 | |||
| Gagnon Robert E. | Sale | -1,348 | $1.13 | $1,523 | 2022-09-21 |
| Paterson Dan | Sale | -2,786 | $1.13 | $3,148 | 2022-09-21 |
| Stuglik Brian M | Sale | -3,355 | $1.13 | $3,791 | 2022-09-21 |
| Stuglik Brian M | Sale | -5,858 | $1.08 | $6,327 | 2022-08-02 |
| Paterson Dan | Sale | -2,701 | $1.14 | $3,079 | 2022-06-22 |
| Gagnon Robert E. | Sale | -1,351 | $1.14 | $1,540 | 2022-06-22 |
| Stuglik Brian M | Sale | -3,362 | $1.14 | $3,833 | 2022-06-22 |
| Gagnon Robert E. | Sale | -16,627 | $1.03 | $17,126 | 2022-05-17 |
| Gagnon Robert E. | Grant, award...etc | 50,000 | 2022-05-17 | ||
| Stuglik Brian M | Sale | -13,794 | $1.03 | $14,208 | 2022-05-17 |
| Stuglik Brian M | Grant, award...etc | 50,000 | 2022-05-17 | ||
| Paterson Dan | Sale | -4,988 | $1.03 | $5,138 | 2022-05-17 |
| Paterson Dan | Grant, award...etc | 15,000 | 2022-05-17 | ||
| Stuglik Brian M | Sale | -5,857 | $1.41 | $8,258 | 2022-05-04 |
| Stuglik Brian M | Sale | -3,507 | $1.27 | $4,454 | 2022-03-23 |
| Paterson Dan | Sale | -2,818 | $1.27 | $3,579 | 2022-03-23 |
| Gagnon Robert E. | Sale | -1,409 | $1.27 | $1,789 | 2022-03-23 |
| BVF PARTNERS L P/IL | Initial | 2022-02-07 | |||
| Stuglik Brian M | Sale | -5,695 | $1.48 | $8,429 | 2022-02-02 |
| Gagnon Robert E. | Sale | -19,612 | $2.05 | $40,205 | 2022-01-05 |
| Stuglik Brian M | Sale | -26,033 | $2.05 | $53,368 | 2022-01-05 |
| Paterson Dan | Sale | -23,534 | $2.05 | $48,245 | 2022-01-05 |
| Stuglik Brian M | Sale | -13,682 | $2.27 | $31,058 | 2021-12-22 |
| Gagnon Robert E. | Sale | -5,497 | $2.27 | $12,478 | 2021-12-22 |
| Paterson Dan | Sale | -10,994 | $2.27 | $24,956 | 2021-12-22 |
| Paterson Dan | Grant, award...etc | 181,500 | 2021-12-17 | ||
| Paterson Dan | Sale | -50,244 | $2.87 | $144,200 | 2021-12-17 |
| Gagnon Robert E. | Grant, award...etc | 148,500 | 2021-12-17 | ||
| Gagnon Robert E. | Sale | -45,329 | $2.87 | $130,094 | 2021-12-17 |
| Stuglik Brian M | Grant, award...etc | 363,000 | 2021-12-17 | ||
| Stuglik Brian M | Sale | -5,839 | $2.59 | $15,123 | 2021-12-17 |
| Stuglik Brian M | Grant, award...etc | 191,828 | 2021-03-29 | ||
| Neumann Frank | Grant, award...etc | 150,000 | 2021-01-08 | ||
| Gagnon Robert E. | Grant, award...etc | 67,925 | 2020-12-22 | ||
| Stuglik Brian M | Grant, award...etc | 203,776 | 2020-12-22 | ||
| Paterson Dan | Grant, award...etc | 135,851 | 2020-12-22 | ||
| BARBERICH TIMOTHY J | Open Market Purchase | 50,000 | $2.17 | 2020-12-07 |
The information provided in this report about VSTM stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Verastem, Inc(NASDAQ:VSTM) 
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing medicines to enhance the life of cancer patients. Its product in development include VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibitor that ...
Website: http://www.verastem.com
Founded: 2010
Full Time Employees: 135
Sector: Healthcare
Industry: Biotechnology